5:38 PM
 | 
Apr 02, 2013
 |  BC Extra  |  Financial News

Optimer jumps on rumors of a take out

Optimer Pharmaceuticals Inc. (NASDAQ:OPTR) jumped $2.24 (19%) to $13.91 on Tuesday after media reports surfaced that at least four companies have expressed interest in acquiring the biotech. The companies rumored to be interested include

Read the full 158 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >